Glabridin CAS 59870-68-7 - Global Strategic Business Report

The global market for Glabridin CAS 59870-68-7 was valued at US$27.5 Billion in 2025 and is projected to reach US$37.2 Billion by 2032, growing at a CAGR of 4.4% from 2025 to 2032. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

Global 'Glabridin (CAS 59870-68-7)' Market - Key Trends & Drivers Summarized

Why Is Glabridin Emerging as a High-Demand Ingredient in the Cosmetics and Health Industry?

Glabridin, a flavonoid compound extracted primarily from licorice root (Glycyrrhiza glabra), is rapidly gaining prominence in the global nutraceutical and cosmetics industries due to its potent skin-lightening, antioxidant, anti-inflammatory, and anti-aging properties. As consumer preference shifts toward naturally derived ingredients, glabridin stands out as a scientifically validated botanical alternative to synthetic actives like hydroquinone or kojic acid, especially in skincare formulations targeting hyperpigmentation, melasma, and uneven skin tone. The compound inhibits tyrosinase activity, which is responsible for melanin production, making it a go-to ingredient in brightening and whitening skincare products. In addition, glabridin is non-irritating, suitable for sensitive skin, and has demonstrated protective effects against UV-induced oxidative stress, further reinforcing its utility in anti-aging and sun care formulations. Beyond cosmetics, glabridin is also explored in functional foods and dietary supplements for its estrogenic, cardiovascular, and neuroprotective benefits. These applications are particularly relevant in markets focused on women’s health and anti-menopausal support. The growing awareness of clean-label formulations, increased R&D into herbal actives, and rising disposable income in emerging economies are further boosting demand. As natural beauty and wellness trends become mainstream across Asia-Pacific, Europe, and North America, glabridin is carving out a niche as a premium bioactive with multifunctional health and cosmetic benefits.

What Are the Key Technological and Manufacturing Trends in the Glabridin Market?

Technological innovation in the extraction, purification, and formulation of glabridin is playing a critical role in enhancing its commercial value and scalability. Traditionally extracted from licorice root using ethanol or water-alcohol solvents, glabridin now benefits from advanced supercritical CO2 extraction methods that yield higher purity and retain bioactivity more effectively. These greener and more efficient extraction techniques align with rising regulatory and consumer demand for sustainable sourcing and environmentally friendly processing. In the realm of formulation, nanoencapsulation and liposomal delivery systems are being adopted to enhance glabridin’s stability, bioavailability, and dermal absorption. These technologies help overcome challenges like low water solubility and potential degradation in topical applications. On the production side, biotech-based fermentation and plant cell culture techniques are emerging as potential alternatives to traditional farming and extraction, enabling controlled, consistent supply while minimizing environmental impact. Manufacturers are also developing standardized glabridin extracts with high active content (≥40%) to meet the purity requirements of pharmaceutical and cosmeceutical formulations. Stringent quality control and traceability mechanisms - especially for exports to Japan, South Korea, and the European Union - are increasingly being adopted to ensure compliance with safety and efficacy standards. These technological advancements not only improve product performance but also allow suppliers to meet the growing demand for high-quality, clean-label ingredients in a competitive global market.

How Are End-Use Sectors and Geographic Markets Influencing Demand Patterns?

The glabridin market is driven by strong demand from several key end-use sectors, notably cosmetics and personal care, dietary supplements, and pharmaceuticals. In cosmetics, glabridin is used extensively in skin whitening creams, anti-aging serums, sunscreens, and post-acne recovery products - making the personal care sector the largest consumer of this compound. Asia-Pacific remains the dominant market due to cultural emphasis on skin brightness and even complexion, with countries like South Korea, China, Japan, and India leading in product launches containing glabridin. Western markets, particularly in Europe and North America, are seeing increased adoption of glabridin in clean beauty and plant-based cosmeceuticals, often marketed as part of premium anti-aging and sensitive skin product lines. In the nutraceutical sector, glabridin is incorporated into supplements aimed at managing metabolic syndrome, menopause symptoms, and cardiovascular health, appealing particularly to aging populations. Pharmaceutical research is also exploring glabridin for potential applications in inflammatory disorders and hormone-related conditions, although these remain largely in the investigational stages. In terms of distribution, both B2B (bulk extract suppliers, cosmetic ingredient companies) and B2C (finished product brands) channels are expanding. Regulatory clarity around botanical extracts in China, the EU, and the U.S. is further facilitating market entry and product approvals. E-commerce growth is accelerating demand across borders, as consumers increasingly seek natural actives with clinical backing. This convergence of industry innovation and regional dynamics is reshaping how glabridin is positioned and consumed globally.

What Factors Are Fueling Growth in the Global Glabridin Market?

The growth in the glabridin (CAS 59870-68-7) market is driven by several interconnected factors tied to industry shifts, consumer behavior, and innovation in product formulation. Foremost is the rising global demand for natural, plant-derived cosmetic actives that offer effective skin benefits without the adverse effects associated with synthetic ingredients. As consumers become more ingredient-conscious, glabridin’s proven efficacy in reducing pigmentation and oxidative stress offers a strong value proposition. Second, the increasing popularity of anti-aging and skin-brightening products - particularly in Asia-Pacific and the Middle East - is fueling demand for high-efficacy botanical ingredients, with glabridin positioned as a premium option. Third, the expansion of functional food and supplement markets - driven by the aging population and interest in hormonal balance and metabolic health - is opening new use cases for glabridin in ingestible formats. On the supply side, advancements in extraction and bioengineering technologies are improving cost-efficiency and scalability, allowing manufacturers to meet rising global demand while maintaining high purity standards. The proliferation of clean-label and vegan-certified products is also creating a favorable regulatory and consumer environment for botanical ingredients like glabridin. Additionally, brand investments in R&D, clinical validation, and marketing are strengthening the credibility and visibility of glabridin-based formulations. Finally, international trade in herbal ingredients is expanding, supported by global sourcing hubs in China, India, and Central Europe. These combined drivers are positioning glabridin as a high-growth ingredient in the broader natural cosmetics and nutraceuticals market, with strong future potential across both established and emerging economies.

Report Scope

The report analyzes the Glabridin CAS 59870-68-7 market, presented in terms of market value (US$). The analysis covers the key segments and geographic regions outlined below:

• Segments: Type (HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent, HPLC 98 percent); Application (Cosmetics Application, Pharmaceuticals Application)
• Geographic Regions/Countries: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Key Insights:

• Market Growth: Understand the significant growth trajectory of the HPLC 20 percent segment, which is expected to reach US$13.4 Billion by 2032 with a CAGR of a 5.5%. The HPLC 40 percent segment is also set to grow at 4.2% CAGR over the analysis period.
• Regional Analysis: Gain insights into the U.S. market, valued at $7.5 Billion in 2025, and China, forecasted to grow at an impressive 7.8% CAGR to reach $7.8 Billion by 2032. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

• Detailed Market Analysis: Access a thorough analysis of the Global Glabridin CAS 59870-68-7 Market, covering all major geographic regions and market segments.
• Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
• Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Glabridin CAS 59870-68-7 Market.
• Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

• How is the Global Glabridin CAS 59870-68-7 Market expected to evolve by 2032?
• What are the main drivers and restraints affecting the market?
• Which market segments will grow the most over the forecast period?
• How will market shares for different regions and segments change by 2032?
• Who are the leading players in the market, and what are their prospects?

Report Features:

• Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2025 to 2032.
• In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
• Company Profiles: Coverage of players such as AIDP, Inc., Alchem International, Alfa Chemicals, Anthony Ingredients, BOC Sciences and more.
• Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Some of the companies featured in this Glabridin CAS 59870-68-7 market report include:

• AIDP, Inc.
• Alchem International
• Alfa Chemicals
• Anthony Ingredients
• BOC Sciences
• Botanic Innovations
• ChemFaces
• Chromadex, Inc.
• CP Kelco
• Euromed S.A.
• FloraTech
• Galaxy Surfactants
• Givaudan
• Guangxi Wuzhou Zhongheng Bio-Tech
• Hebei Yele Biotechnology
• Indena S.p.A.
• Jiangxi Shenzhou Biological
• Layn Natural Ingredients
• Lonza Group AG
• Natreon, Inc.

What Sets This Report Apart From Others?

• Grounded in Domain Expert Perspectives: Incorporates perspectives emerging from domain experts across industry, enterprise and academia, adding context beyond conventional published research.
• Captures Early Market Signals: Tracks shifts emerging through expert conversations, company activity and market-relevant discussions before they are fully reflected in traditional secondary research.
• Draws From a Broad, Validated Intelligence Base: Brings together insights from conference sessions, keynotes, panel discussions, blogs, corporate disclosures, annual reports, institutional publications and other validated sources.
• Connects Signals With Strategic Market Direction: Synthesizes these perspectives to identify where the market is moving, what is driving that movement and which developments are likely to matter most for strategy.
• Provides In-Depth Company Intelligence: Extends beyond market-level analysis to examine the companies participating in and shaping the competitive environment.
• Market Share Is Examined Where It Matters: A single global market share figure rarely tells the full story. Competitive structures can vary significantly across geographies. Where analytically relevant, the report extends market share analysis into major regions with the level of detail tailored to the structure and dynamics of each market.